Hologic's Q4 Revenues Rise 26 Percent on Gen-Probe Contribution
November 13, 2012
Hologic's Q4 Revenues Rise 26 Percent on Gen-Probe Contribution
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Gen-Probe Acquisition Drives up Hologic's Q2 Revenues 30 Percent
May 6, 2013 / GenomeWeb Daily News - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - Hologic Terminating Wisconsin Workers in MDx Relocation; Discloses Gen-Probe Revenue Contributions in Q1
February 8, 2013 / GenomeWeb Daily News